Jill A. Greytok

Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.

R.E. Rose, Ying Gong, Jill A. Greytok et al. · Proceedings of the National Academy of Sciences · 1996 · 117 citations

Protease Inhibitors, Major Role, Medicine +15

Amino Diol HIV Protease Inhibitors. 1. Design, Synthesis, and Preliminary SAR

Joel C. Barrish, Eric M. Gordon, Masud Alam et al. · Journal of Medicinal Chemistry · 1994 · 67 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +15

Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor

Amy K. Patick, R.E. Rose, Jill A. Greytok et al. · Journal of Virology · 1995 · 55 citations · Full text

Aminodiol Protease Inhibitor, Immunology, Antiviral Drug +18

Aminodiol HIV Protease Inhibitors. Synthesis And Structure−Activity Relationships Of P₁/P₁‘ Compounds:  Correlation between Lipophilicity and Cytotoxicity

Ping Chen, Peter T. W. Cheng, Masud Alam et al. · Journal of Medicinal Chemistry · 1996 · 37 citations · Full text

Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single‐blind, placebo‐controlled study in F2/F3 NASH

Stephen A. Harrison, Patrick Mayo, Todd M. Hobbs et al. · Hepatology Communications · 2022 · 27 citations · Full text